FDA Approved: FOCALIN XR — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application for FOCALIN XR, submitted by Sandoz Inc, indicating an approved modification to the product’s labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• FOCALIN XR (DEXMETHYLPHENIDATE HYDROCHLORIDE)

Snippet

SUPPL AP for FOCALIN XR (DEXMETHYLPHENIDATE HYDROCHLORIDE)